Top Healthcare and Biotech Focused Hedge Funds Oversee $43 Billion in Equity Assets
|July 6th, 2013||
|The Top 50 Healthcare, Pharmaceutical and Biotechnology Focused Hedge Fund list has been released, revealing that the top hedge funds now manage $43 billion in U.S. equity assets. The top 50 hedge funds allocate $29.8 billion, or 69% of their total equity assets, to Healthcare, Pharma & Biotech stocks.|
The Top Healthcare, Pharma & Biotech Hedge Fund List is led by #1 Larry Robbins’ Glenview Capital Management and #2 Samuel Isaly‘s OrbiMed Advisors. The two top funds swapped spots on this quarter’s list, as OrbiMed Advisors had most recently been ranked #1, while Glenview Capital was #2 on the 12/31/2012 ranking. While Isaly’s OrbiMed Advisors is purely a healthcare focused investor, Robbins’ Glenview Capital is a global long/short equity investor that opportunistically makes big sector bets.
Some notable hedge funds at the top of the hedge fund list include #5 Healthcor Partners and #8 Palo Alto Investors. New York City-based Healthcor Partners is a healthcare focused hedge fund manager that is led by portfolio managers Arthur Cohen and Joseph Healey. The firm, which was originally a part of SAC Capital Advisors, reported having U.S. equity assets of $2.1 billion, dedicating 85.6% of its assets to Healthcare, Pharma & Biotech equities.
William Edwards’ growth focused Palo Alto Investors reported U.S. equity assets of $844 million, dedicating 100% of its assets to Healthcare, Pharma & Biotech equities. The California-based firm focuses on healthcare and biotech stocks, typically concentrating its portfolio on 30 to 40 top stocks.
Ranking Methodology: The Top Healthcare, Pharmaceutical and Biotechnology Hedge Fund rankings are compiled on a quarterly basis using hedge fund firms’ overall U.S. equity assets under management. The list includes the top hedge funds that have more than 35% of their U.S. equity assets invested in U.S. listed Healthcare, Pharma & Biotech companies, as of 12/31/2012. To view the Top Healthcare, Pharma & Biotech Hedge Fund list in its entirety, please visit HedgeTracker’s Hedge Fund Portal.
For Detailed Investor Profiles on these Investors, click below: